MMedication Read More New Drug for Tourette Syndrome Effective for Kids and AdultsOctober 14, 2025 HONOLULU — The investigational dopamine-1 (D1) receptor antagonist ecopipam (developed by Emalex Biosciences) is safe and effective for…
MMedication Read More When GLP-1s Change Patients’ Libido: What to KnowSeptember 30, 2025 It’s not discussed as often as other side effects of GLP-1 receptor agonists, but one adverse effect is…
MMedication Read More FDA Seeks Schedule I Status for ‘Legal Morphine’July 31, 2025 The FDA is recommending that 7-hydroxymitragynine (7-OH), a synthetic, concentrated substance derived from kratom leaves, be classified as…
MMedication Read More Most GLP-1 Prescriptions Miss the Mark: Are Yours?July 28, 2025 GLP-1 receptor agonists, including semaglutide, are now widely used for weight loss, offering substantial weight reduction, improved metabolic…